Allspring Discloses 8.7% Stake in Zepp Health (ZEPP) – 9.76M ADRs
Allspring Global Investments Holdings, LLC has filed Amendment No. 7 to Schedule 13G declaring its current ownership in Zepp Health Corp (symbol ZEPP) as of 30 June 2025.
Rhea-AI Filing Summary
Allspring Global Investments Holdings, LLC has filed Amendment No. 7 to Schedule 13G declaring its current ownership in Zepp Health Corp (symbol ZEPP) as of 30 June 2025.
- Shares owned: 9,757,152 American Depositary Receipts (ADRs).
- Ownership percentage: 8.7 % of the outstanding ADR class, exceeding the 5 % reporting threshold.
- Voting/dispositive power: Sole voting power and sole dispositive power over the entire position; no shared power reported.
- Holder classification: Designated as a Holding Company/Control person (Item 3 — HC).
- Stake origin: Securities are held for clients of subsidiaries Allspring Global Investments, LLC and Allspring Funds Management, LLC; no single client holds more than 5 % of the class.
- Intent statement: Filing certifies the position was acquired in the ordinary course of business and not to influence control of Zepp Health.
- Signatories & dates: Event date 06-30-2025; filing signed by Senior Compliance Manager Jennifer Grunberg on 07-14-2025.
This disclosure signals a sizeable passive institutional position in Zepp Health, potentially viewed by the market as a vote of confidence in the company’s prospects without implying activist intentions.
Positive
- Institutional ownership of 8.7 % indicates strong passive confidence from Allspring, enhancing ZEPP’s shareholder base and liquidity.
- Sole voting and dispositive power provide Allspring clear decision authority on its shares, reducing complexity around potential vote splits.
Negative
- None.
Insights
TL;DR: Allspring’s 8.7 % passive stake reveals material institutional support for ZEPP.
Allspring’s sole-controlled holding of 9.76 million ADRs places it among Zepp Health’s largest shareholders. The absence of shared voting/dispositive power and the ordinary-course certification indicate a non-activist, portfolio-allocation motive. Still, surpassing the 5 % threshold gives Allspring influence over shareholder votes and reflects confidence in Zepp’s valuation. For investors, the filing removes uncertainty around ownership concentration and points to a deeper institutional investor base, which can improve liquidity and potentially reduce volatility.
TL;DR: Passive 13G suggests no control agenda, but a meaningful anchor investor for ZEPP.
An 8.7 % position is significant for any sub-$1 billion market-cap issuer. While purely passive, Allspring’s vote can sway key resolutions, especially given historically low turnout in ADR-listed Chinese equities. For existing shareholders, the visibility of a notable U.S. asset manager may broaden analyst coverage and attract similar funds. No immediate dilution or governance change is implied, so the impact skews modestly positive.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Zepp Health (ZEPP) does Allspring Global Investments own?
How many Zepp Health ADRs are held by Allspring according to the filing?
Why did Allspring file Amendment No. 7 to Schedule 13G for Zepp Health?
When were the event and filing dates for Allspring’s Schedule 13G?
Which Allspring subsidiaries are linked to the ZEPP holdings?
How is Allspring classified in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.